Crossing Boundaries, Guarding Health — Gene Target Group Leads with Data and DNA
發布日期：
Preventive Medicine on the Rise: Gene Target Group Wins Acclaim for Pioneering Genetic Health Solutions
The ancient Chinese medical classic Huangdi Neijing (The Yellow Emperor’s Inner Canon) stated:
“Inferior doctors treat diseases that have already developed,
Average doctors treat diseases that are about to develop,
Superior doctors prevent diseases before they arise.”
This concept perfectly embodies the modern principle of preventive medicine, which is rapidly gaining momentum in Taiwan as the healthcare industry matures and the focus shifts toward proactive health management.
One standout example in this field is Gene Target Biotech, which was honored this year (2022) with the 4th Golden Ship Award by the National Chamber of Commerce. Its founder and chairperson, Dr. Yifang Chen, comes from a medical background. Witnessing the unending stream of patients in hospitals, she developed a deep awareness of the critical need to prevent illness before it begins. Over two decades ago, she began her journey into genetic research to find truly precise ways to prevent disease.
Decoding the Genetic Blueprint: Understanding Individual Traits and Needs
“Every person is born with a unique genetic code. The differences in this code determine our physical health, personality traits, and even disease susceptibility,”
Dr. Chen explains.
She realized that precision preventive medicine starts with a deep understanding of one’s genetic makeup. By assessing the body’s internal state and how it interacts with environmental factors, a more systematic and customized approach to disease prevention can be implemented. This insight drove her to establish a company focused entirely on genetic science.
Founded over a decade ago, Gene Target’s core mission has been 'Precision Wellness'.
“We aim to care for people’s health using the most precise methods available,” says Dr. Chen.
“And the most fundamental and accurate scientific tool we have is the gene.”
The word "gene" literally means "the most basic unit"—like a user manual for the body.
“Gene Target is here to help decode that manual,” Dr. Chen elaborates.
“We don't just identify your genetic code—we interpret what it means. Our goal is to help people understand their body’s unique characteristics and health needs through precise genetic testing.”
This scientific yet personalized approach marks a major shift from reactive medicine to proactive, preventive care—and Gene Target Group is leading that transformation.
24/7 Professional Personal Health Steward System
In recent years, Gene Target Group has successfully integrated innate genetic data with acquired physiological big data and artificial intelligence technology to develop the patented 24-hour personal health management system, GeneCare. Although genetic testing provides users with professional results and recommendations, many still find it challenging to fully adhere to these health instructions. Dr. Yifang Chen points out this gap as the motivation behind creating a personal health steward:
“Gene Target utilizes exclusive inventions combining innate and acquired data integration along with a precise intelligent health system to develop a professional health steward app. Paired with our patented wearable device, it continuously monitors physiological metrics such as heart rate, blood pressure, blood oxygen, step count, and sleep quality. These real-time data are analyzed and tracked constantly, and when integrated with genetic information, deliver a comprehensive intelligent health management service. This empowers users with a 24/7, year-round health steward to provide the most precise health protection.”
Meeting Health Needs Amid the Pandemic
With the pandemic making people reluctant to go out or visit hospitals and clinics, Dr. Chen emphasizes:
“This is when a health management tool like GeneCare is especially necessary, allowing everyone to access professional health services anytime, anywhere—even without leaving their homes.”
Gene-Based Medicine and Cross-Industry Collaboration for Maximum Impact
Health involves not only physical but also mental well-being, including personality and talents. Over ten years ago, Gene Target expanded its genetic research and services into this psychological domain.
“We have bridged genetic technology into education,” Dr. Chen says with anticipation.
“After more than a decade of genetic testing, we have accumulated vast amounts of health data that can benefit many industries. For example, in the insurance sector in the U.S., genetic testing has helped reduce cancer cases by over one million people, lowering insurance claims and premiums, while improving public health and national productivity.”
Dr. Chen envisions collaborations beyond healthcare:
-
Working with real estate developers to design living environments tailored to residents’ health and personalities.
-
Partnering with restaurants to offer menus customized by genetic profiles.
-
Enabling convenience stores to stock foods suited for different genetic types.
“Gene Target can’t do all this alone—we want to be an aircraft carrier with many fighter jets joining,” she explains.
To promote cross-industry cooperation, Gene Target has taken the lead by developing gene-based beauty products such as “QiJi” masks and serums. They recently launched a new brand, Yuan Health, offering gene-targeted metabolic chocolates and supplements, with plans to incorporate nutrition into food and collaborate with chain restaurants.
Building an Intelligent Biotech Factory to Expand International Markets
Genetic technology has traditionally been a niche in health care, but Dr. Chen believes the pandemic has increased public awareness.
Winning the prestigious Golden Ship Award this year for GeneCare, the system is based on preventive medicine principles and combines rich technology and medical expertise.
“Our ‘E-Steward’ system reminds users about diet and supplements based on their body’s needs. This allows us to build a platform matching users with suitable health products through their genetic profiles. Gene Target is only the pioneer; we hope more companies will join in.”
Looking ahead, Gene Target plans to launch a public listing this year and establish an intelligent biotech factory within Taiwan’s National Science Park. This facility will house a precision big data center, standardized genetic services, and a cell standardization plant—forming the foundation for international expansion over the next decade.
Globally, Gene Target aims to build a satellite network of over 10,000 service points, extending Taiwan’s advanced intelligent health and biotech medical achievements worldwide, and becoming a leading global brand in precision health care.
